• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 16 (8), 2020
  3. 529-541
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2020 | Volume: 16 | Issue: 8 | Page No.: 529-541
DOI: 10.3923/ijp.2020.529.541

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 454

Authors


Talha  Jawaid

Talha Jawaid

LiveDNA: 91.24416

Kalpana

Country: India

Mehnaz  Kamal

Mehnaz Kamal

LiveDNA: 91.11064

Nitin  Verma

Nitin Verma

LiveDNA: 91.17967

Osama A. Alkhamees

Country: Saudi Arabia

Ali M. Alaseem

Country: Saudi Arabia

Saud M. Alsanad

Country: Saudi Arabia

Keywords


  • behavioral studies
  • piracetam
  • RT-PCR
  • scopolamine
  • Selegiline
  • streptozotocin
  • western blot test
Research Article

Neuroprotective Effects of Co-Administration of Selegiline with Piracetam on Cognitive Impairment: Involvement of NR2B, NR1 and Bax Signaling Pathway

Talha Jawaid Talha  Jawaid's LiveDNA, Kalpana, Mehnaz Kamal Mehnaz  Kamal's LiveDNA, Nitin Verma Nitin  Verma's LiveDNA, Osama A. Alkhamees, Ali M. Alaseem and Saud M. Alsanad
Background and Objective: Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder characterized by loss of memory due to phosphorylation of tau protein, neurofibrillary lesions composed of the β-amyloid peptide and aberrant oxidative stress. The objective is to study the combined neuroprotective effect of Selegiline with Piracetam against scopolamine and streptozotocin (STZ)-induced memory impairment in animals. Materials and Methods: This study was designed to investigate the synergistic neuroprotective effect of Selegiline with Piracetam by use of scopolamine and STZ model of memory impairment using the Morris water maze for the assessment of learning and memory. Various biochemical parameters such as acetylcholinesterase activity (AChE) as a marker of cholinergic activity, malondialdehyde (MDA) a marker of lipid peroxidation and glutathione (GSH) a marker of oxidative stress were estimated. Gene expression was also performed by RT-PCR and western blot test. Results: There were a significant decrease in MDA and AChE level and increase in GSH level as compared to the disease control group in Selegiline with Piracetam. In the present study, Bax and Bak mRNA (proapoptotic) were down-regulated, while Bcl-2 mRNA and protein which are antiapoptotic were up-regulated in Selegiline with Piracetam group opposite to the STZ group. Also, p53 expression in the given experiment was appreciably reduced in Selegiline with Piracetam group. Conclusion: The present study indicates that the administration of scopolamine and STZ cause a decline in memory function which is significantly improved by the treatment of selegiline with piracetam. The combined effect of selegiline with piracetam was found to be therapeutically more effective than the individual administration.
PDF Fulltext XML References Citation

How to cite this article

Talha Jawaid, Kalpana, Mehnaz Kamal, Nitin Verma, Osama A. Alkhamees, Ali M. Alaseem and Saud M. Alsanad, 2020. Neuroprotective Effects of Co-Administration of Selegiline with Piracetam on Cognitive Impairment: Involvement of NR2B, NR1 and Bax Signaling Pathway. International Journal of Pharmacology, 16: 529-541.

DOI: 10.3923/ijp.2020.529.541

URL: https://scialert.net/abstract/?doi=ijp.2020.529.541

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved